Better sleep quality Sermorelin and GH are both linked with better sleep patterns
It probably will not replace tirzepatide for people pursuing maximum weight loss, given the roughly 2x efficacy gap
Who Is a Good Candidate for GHK-Cu
Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect

In clinical trials, patients using Wegovy achieved an average weight loss of 12-15% of their body weight over 68 weeks, making it one of the most effective weight loss medications available